Overview


According to FutureWise analysis the market for Periodic Fever Syndrome is expected to register a CAGR of 4.10% from 2023-2031.

Periodic Fever Syndrome is an autoinflammatory disease that causes episodic illness. It does not have an infectious cause. Periodic Fever Syndrome is a genetic condition that can also be present in childhood. It is determined by genetic testing and clinical features. The affected area, age, and location of the patient are all important. Understanding the gene defect is key to treatment. Although there are similarities in the symptoms of periodic fever syndrome, they have different patterns of inheritance, causes, and frequency of attacks. Periodic Fever Syndrome can affect many organs and tissues. It also has high temperatures during attacks. Periodic fever syndrome is associated with elevated serum levels of acute phase reactants like fibrinogen, serum amyloid A, and leukocytosis. Periodic fever patients have access to diagnostic tools and genetic tests. There are no genetic tests available for some conditions, such as Periodic Fever (PFAPA), Aphthous Stomatitis (PF), Pharyngitis, Adenitis Syndrome, Pharyngitis (PFAPA), and Pharyngitis Syndrome. HPFSs, which are hereditary periodic fever syndromes (HPFSs), are uncommon and can be characterized by recurrent and short-term attacks. These attacks are remissionable without the need for anti-inflammatory, immunosuppressive, or antibiotic treatment. The patient feels well and can return to their daily activities until the next episode. TNF Receptor-Associated Periodic Syndrome (TRAPS),

Hyperimmunoglobulinemia D Syndrome (HIDS), and Mevalonate Kinase Deficiency were previously unaddressed medical conditions (MKD).
Oral anti-inflammatory drugs (e.g. Oral anti-inflammatory drugs, such as corticosteroids or non-steroidal anti-inflammatory drugs (NSAIDs), can be used to manage the symptoms but not prevent Periodic Fever Syndrome. Market growth will be driven by the rise in periodic fever syndrome. The rising healthcare spending is another factor that will influence the market growth. The market will grow due to technological advancements, increased awareness campaigns by both public and private organizations, and increased government funding. The periodic fever market will also be impacted by the rising demand for effective treatments and a growing geriatric population. The market will also grow due to high disposable income and an inclination toward a sedentary lifestyle. The periodic fever market will also benefit from the increase in research and development activities as well as the launch of new effective therapies. The market will grow at a faster rate due to unmet medical needs and advancements in healthcare technology. The market's growth will be slowed by the high costs associated with treatment and the lack of infrastructure in low-income countries. The market growth for periodic fever syndromes will be hampered by the complications that come with the disease. The market will be further challenged by a lack of technical skills and less awareness.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Periodic Fever Syndrome Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Periodic Fever Syndrome Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Novartis AG
  • Simvastatin
  • Merck & Co Inc
  • Swedish Orphan Biovitrum AB

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Indication

  • Hyperimmunoglobulinemia D Syndrome (HIDS)
  • Familial Mediterranean Fever (FMF)
  • TNF Receptor-Associated Periodic Syndrome (TRAPS)
  • Cryopyrin-Associated Periodic Syndrome (CAPS)
  • Others

By Treatment

  • Oral anti-inflammatory drugs (corticosteroid)
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Anti-TNF therapy
  • Statins
  • Others

By End-User

  • Hospitals
  • Retail pharmacy

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Periodic Fever Syndrome Market By Indication, By Treatment, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Periodic Fever Syndrome Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Periodic Fever Syndrome Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Periodic Fever Syndrome Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Periodic Fever Syndrome Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hyperimmunoglobulinemia D Syndrome (HIDS)
        2. Familial Mediterranean Fever (FMF)
        3. TNF Receptor-Associated Periodic Syndrome (TRAPS)
        4. Cryopyrin-Associated Periodic Syndrome (CAPS)
        5. Others

  • 8.   Periodic Fever Syndrome Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral anti-inflammatory drugs (corticosteroid)
        2. Non-steroidal anti-inflammatory drugs (NSAIDs)
        3. Anti-TNF therapy
        4. Statins
        5. Others

  • 9.   Periodic Fever Syndrome Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Retail pharmacy

  • 10.   North America Periodic Fever Syndrome Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Periodic Fever Syndrome Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Periodic Fever Syndrome Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Periodic Fever Syndrome Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Periodic Fever Syndrome Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Novartis AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Simvastatin
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck & Co Inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Swedish Orphan Biovitrum AB
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients